Compass Pathways will attend the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

LONDON & NEW YORK –

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to rapidly innovating for global prosperity, has announced its decision on the appointment of management teams at 1:20 p.m. on September 26, 2024. Uhr ET has conducted a study to share the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit.

A live audio broadcast of chats will be displayed on the events page of the Compass website and archived for 30 days.

Compass paths

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company focused on developing patients with evidence innovation in the context of the wonderful knowledge they develop. Part of the Schwerpunkt lies in the knowledge of the human quality, who with his physical problems live and the best quality of the standards does not help. Pioneering work has been done in the discovery of a new model of psilocybin treatment, in our reinforced proprietary formulation of synthetic psilocybin, COMP360, in the processing with psychological explanations. COMP360 is one of the US-American Food and Drug Administration (FDA) that has developed the status of a therapy practice in the United Kingdom for the treatment of depression therapies (TRD) as an Innovative Licensing and Access Pathway (ILAP) developed.

A Phase 3 clinical program using COMP360 psilocybin treatment has been initiated at TRD, the large randomized, controlled, double-blind clinical psilocybin treatment program, which is conducted over time. If you have completed a Phase 2b study, there is significant statistical significance (p

Compass at Hauptsitz in London, Great Britain and Niederlassungen in New York and San Francisco in the USA. Our Vision is a world of the spiritual world.

Verfügbarkeit other information about compass paths

Investors and other persons can get in touch with each other on our website (www.compasspathways.com), our Investor Relations website (ir.compasspathways.com) and in the social media (LinkedIn). There is no description of investor presentations and investor fact sheets, US-US stock budgets, press conferences, telephone conferences and webcasts. The information, which is displayed via these channels and websites, can be used as general information. The company works together with Investors, the Media and others and our interested persons, who on those Channels, one of the Investor Relations website, view information about the regulatory information about the überprüfen. This list of channels can be placed from time to time on our Investor Relations website and the social media channels are expanded. The removal of a website or that other website, on another website or that other website can no longer be used by the publication of a US paper store from 1933.

The general text, in the original text that is light, is the official and authorized version. The settings must be adjusted. Only the Sprachversion, the original veröffentlichte wurde, is legally valid. Use the original version of the display ab.